In a meta-analysis, researchers found no difference in all-cause mortality for intensive-care patients with fluid overload who were treated with loop diuretics, compared with those given a placebo or ...

Acetazolamide added to intravenous loop diuretics decreases congestion within three days in patients with acute decompensated heart failure, according to late breaking research presented in a Hot Line ...

Early findings suggest Aquadex as a potential solution to safely and effectively remove fluid volume for liver disease patients who don’t respond to diuretics MINNEAPOLIS, Feb. 06, 2024 (GLOBE ...

MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NUWE) Nuwellis, Inc., a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to ...

Adding acetazolamide to conventional loop diuretics can improve the rate of decongestion in hospitalized acute decompensated heart failure (HF) patients better than diuretics alone, according to data ...

EDEN PRAIRIE, Minn., June 23, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the company will host an interactive, physician-led webinar to discuss treatment of fluid overload ...

Nuwellis Inc (NASDAQ:NUWE) saw its stock decline by 10% after announcing it will discontinue its REVERSE-HF clinical trial, which was assessing the effectiveness of ultrafiltration versus intravenous ...

MINNEAPOLIS, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, addressing the ...

Note: alfa pump® and DSR® are registered trademarks.